Pre-order Enquiry
Request Free Sample
Global Cancer Vaccines Market Research Report 2021
SKU ID : QYR-17222482 | Publishing Date : 20-Jan-2021 | No. of pages : 96
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient's immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
The global Cancer Vaccines market was valued at US$ 4755.6 million in 2019 and is expected to reach US$ 12220 million by the end of 2026, growing at a CAGR of 14.3% during 2021-2026.
This report focuses on Cancer Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cancer Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Segment by Application
Cervical Cancer
Prostate Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient's immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
The global Cancer Vaccines market was valued at US$ 4755.6 million in 2019 and is expected to reach US$ 12220 million by the end of 2026, growing at a CAGR of 14.3% during 2021-2026.
This report focuses on Cancer Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cancer Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Segment by Application
Cervical Cancer
Prostate Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
